Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 21, Issue 9, 2014, Pages 3063-3068

  Itoh, Shinji ^a   Shirabe, Ken ^a   Matsumoto, Yoshihiro ^a   Yoshiya, Shohei ^a   Muto, Jun ^a   Harimoto, Norifumi ^a   Yamashita, Yo Ichi ^a   Ikegami, Toru ^a   Yoshizumi, Tomoharu ^a   Nishie, Akihiro ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY MASS; CANCER SURGERY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INCIDENCE; INTRAABDOMINAL FAT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE COMPLICATION; RECURRENCE FREE SURVIVAL; SARCOPENIA; SURGICAL MORTALITY; UMBILICUS; VERY ELDERLY; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; COMPLICATION; FOLLOW UP; JAPAN; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INCIDENCE; INTRA-ABDOMINAL FAT; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84906237520     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3686-6     Document Type: Article

References (35)

1. Bruix J, Lovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519-24. (Pubitemid 34183954)
2. Bosch FX, Ribes J, Díaz M, et al. Primary liver cancer: worldwide incidence and trends (review). Gastroenterology. 2004;127:S5-16.
3. Takenaka K, Kawahara N, Yamamoto K, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996;131:71-6. (Pubitemid 26015411)
4. Shirabe K, Takeishi K, Taketomi A, et al. Improvement of longterm outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. World J Surg. 2011;35:1072-84.
5. Itoh S, Morita K, Ueda S, et al. Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas. Ann Surg Oncol. 2009;16:3299-307.
6. Yamashita Y-i, Taketomi A, Itoh S, et al. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma. J Am Coll Surg. 2007;205:19-26. (Pubitemid 47016949)
7. Itoh S, Fukuzawa K, Shitomi Y, et al. Impact of the VIO system in hepatic resection for patients with hepatocellular carcinoma. Surg Today. 2012;42:1176-82.
8. Uchiyama H, Itoh S, Higashi T, et al. A two-step hanging maneuver for a complete resection of Couinaud's segment I. Dig Surg. 2012;29:202-5.
9. Taketomi A, Kitagawa D, Itoh S, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg. 2007;204:580-7. (Pubitemid 46428578)
10. Itoh S, Shirabe K, Taketomi A, et al. Zero mortality in more than 300 hepatic resections: validity of preoperative volumetric analysis. Surg Today. 2012;42:435-40.
11. Merkow RP, Bilimoria KY, McCarter MD, et al. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009;208:53-61.
12. Mullen JT, Davenport DL, Hutter MM, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2007;15:2164-72.
13. Itoh S, Ikeda Y, Kawanaka H, et al. The effect of overweight status on the short-term and 20-y outcomes after hepatic resection in patients with hepatocellular carcinoma. J Surg Res. 2012;178:640-5.
14. Sugisawa N, Tokunaga M, Tanizawa Y, et al. Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer. 2012;15:206-12.
15. Cecchini S, Cavazzini E, Marchesi F, et al. Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg. 2011;35:415-23.
16. Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523-30.
17. Kvist H, Chowdhury B, Sjöström L, et al. Adipose tissue volume determination in males by computed tomography and 40 K. Int J Obes. 1988;12:249-66.
18. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211:283-6. (Pubitemid 29161765)
19. Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48:58-62.
20. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complication: five-year experience. Ann Surg. 2009;250:187-96.
21. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva, Switzerland: World Health Organization; 2000.
22. Kashihara H, Lee JS, Kawakubo K, et al. Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of cardiovascular risk factors. Circ J. 2009;73:1881-6.
23. Mano Y, Shirabe K, Yamashita Y, et al. Preoperative neutrophil-to- lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013;258:301-5.
24. Shirabe K, Itoh S, Yoshizumi T, et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma - with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol. 2007;95:235-40.
25. Itoh S, Maeda T, Shimada M, et al. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res. 2004;10:2812-7. (Pubitemid 38509160)
26. Takeishi K, Taketomi A, Shirabe K, et al. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway. J Hepatol. 2012;57:77-83.
27. Gaujoux S, Torres J, Olson S, et al. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol. 2012;19:2908-16.
28. Saunders JK, Rosman AS, Neihaus D, et al. Safety of hepatic resections in obese veterans. Arch Surg. 2012;147:331-7.
29. Dindo D, Muller MK, Weber M, et al. Obesity in generalelective surgery. Lancet. 2003;361:2032-5.
30. van Vledder MG, Levolger S, Ayez N, et al. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550-7.
31. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-7. (Pubitemid 46024993)
32. Sacks GS, Dearman K, Replogle WH, et al. Use of subjective global assessment to identify nutrition-associated complications and death in geriatric long-term care facility residents. J Am Coll Nutr. 2000;19:570-577.
33. Pausch T, Hartwig W, Hinz U, et al. Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery. 2012;152(3 Suppl 1):S81-8.
34. Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433-450.
35. Lang T, Streeper T, Cawthon P, et al. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int. 2010;21:543-59.